Characterization of erythromycin-resistant Streptococcus pneumoniae in Korea, and in vitro activity of telithromycin against erythromycin-resistant Streptococcus pneumoniae

Microbial Drug Resistance

Volumn 11, Issue 3, 2005, Pages 260-265

  Kim, Nam Joong ^a,b   Park, Su Jin ^b   Choi, Sang Ho ^a,b   Lee, Mi Suk ^a,b   Choo, Eun Ju ^a,b   Kwak, Yee Gyung ^a,b   Woo, Jun Hee ^a,b   Ryu, Jiso ^a,b   Jeong, Jin Yong ^a,b   Kim, Yang Soo ^a,b,c  

^a University of Ulsan College of Medicine   (South Korea)

^b University of Ulsan   (South Korea)

^c Asan Medical Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CLINDAMYCIN; ERYTHROMYCIN; JOSAMYCIN; MACROLIDE; TELITHROMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; COLONY FORMING UNIT; GENOTYPE; KOREA; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; GENOTYPE; KETOLIDES; KOREA; MICROBIAL SENSITIVITY TESTS; PHENOTYPE; STREPTOCOCCUS PNEUMONIAE;

STREPTOCOCCUS PNEUMONIAE;

EID: 26444434888     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.2005.11.260     Document Type: Article

References (37)

1. Angot, P., M. Vergnaud, M. Auzou, and R. Leclercq. 2000. Macrolide resistance phenotypes and genotypes in French clinical isolates of Streptococcus pneumoniae. Observatoire de Normandie du Pneumocoque. Eur. J. Clin. Microbiol. Infect. Dis. 19:755-758.
2. Baquero, F., J.A. Garcia-Rodriguez, J. Garcia de Lomas, and L. Aguilar. 1999. Antimicrobial resistance of 1,113 Streptococcus pneumoniae isolates from patients with respiratory tract infections in Spain: results of a 1-year (1996-1997) multicenter surveillance study. The Spanish Surveillance Group for Respiratory Pathogens. Antimicrob. Agents Chemother. 43:357-359.
3. Betriu, C., M. Redondo, M.L. Palau, A. Sanchez, M. Gomez, E. Culebras, A. Boloix, and J.J. Picazo. 2000. Comparative in vitro activities of linezolid, quinupristin-dalfopristin, moxifloxacin, and trovafloxacin against erythromycin-susceptible and -resistant streptococci. Antimicrob. Agents Chemother. 44:1838-1841.
4. Corso, A., E.P. Severina, V.F. Petruk, Y.R. Mauriz, and A. Tomasz. 1998. Molecular characterization of penicillin-resistant Streptococcus pneumoniae isolates causing respiratory disease in the United States. Microb. Drug Resist. 4:325-337.
5. Del Grosso, M., F. Iannelli, C. Messina, M. Santagati, N. Petrosillo, S. Stefani, G. Pozzi, and A. Pantosti. 2002. Macrolide efflux genes mef(A) and mef(E) are carried by different genetic elements in Streptococcus pneumoniae. J. Clin. Microbiol. 40:774-778.
6. Doern, G.V., K.P. Heilmann, H.K. Huynh, P.R. Rhomberg, S.L. Coffman, and A.B. Brueggemann. 2001. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000, including a comparison of resistance rates since 1994-1995. Antimicrob. Agents Chemother. 45:1721-1729.
7. Doern, G.V., M.A. Pfaller, K. Kugler, J. Freeman, and R.N. Jones. 1998. Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program. Clin. Infect. Dis. 27:764-770.
8. Edelstein, P.H. 2004. Pneumococcal resistance to macrolides, lincosamides, ketolides, and streptogramin B agents: molecular mechanisms and resistance phenotypes. Clin. Infect. Dis. 38(Suppl 4):S322-S327.
9. Farrell, D.J., I. Morrissey, S. Bakker, S. Buckridge, and D. Felmingham. 2004. In vitro activities of telithromycin, linezolid, and quinupristin- dalfopristin against Streptococcus pneumoniae with macrolide resistance due to ribosomal mutations. Antimicrob. Agents Chemother. 48:3169-3171.
10. Farrell, D.J., I. Morrissey, S. Bakker, L. Morris, S. Buckridge, and D. Felmingham. 2004. Molecular epidemiology of multiresistant Streptococcus pneumoniae with both erm(B)- and mef(A)-mediated macrolide resistance. J. Clin. Microbiol. 42:764-768.
11. Felmingham, D., R.R. Reinert, Y. Hirakata, and A. Rodloff. 2002. Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study, and compatative in vitro activity of the ketolide, telithromycin. J. Antimicrob. Chemother. 50(Suppl S1):25-37.
12. Hoban, D.J., A.K. Wierzbowski, K. Nichol, and G.G. Zhanel. 2001. Macrolide-resistant Streptococcus pneumoniae in Canada during 1998-1999: prevalence of mef(A) and erm(B) and susceptibilities to ketolides. Antimicrob. Agents Chemother. 45: 2147-2150.
13. Hsueh, P.R., L.J. Teng, L.N. Lee, P.C. Yang, S.W. Ho, B.C. Lue, and K.T. Luh. 2002. Increased prevalence of erythromycin resistance in streptococci: substantial upsurge in erythromycin-resistant M phenotype in Streptococcus pyogenes (1979-1998) but not in Streptococcus pneumoniae (1985-1999) in Taiwan. Microb. Drug. Resist. 8:27-33.
14. Jalava, J., J. Kataja, H. Seppala, and P. Huovinen. 2001. In vitro activities of the novel ketolide telithromycin (HMR 3647) against erythromycin-resistant Streptococcus species. Antimicrob. Agents Chemother. 45:789-793.
15. Johnson, A.P., C.J. Henwood, L. Tysall, and M. Warner. 2001. Activity of the ketolide telithromycin (HMR-3647) against erythromycin-susceptible and -resistant pneumococci isolated in the UK. Int. J. Antimicrob. Agents. 18:73-76.
16. Kelley, M.A., D.J. Weber, P. Gilligan, and M.S. Cohen. 2000. Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin. Clin. Infect. Dis. 31:1008-1011.
17. Leclercq, R., and P. Courvalin. 1991. Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification. Antimicrob. Agents Chemother. 35:1267-1272.
18. Melo-Cristino, J., M. Ramirez, N. Serrano, and T. Hanscheid. 2003. Macrolide resistance in Streptococcus pneumoniae isolated from patients with community-acquired lower respiratory tract infections in Portugal: results of a 3-year (1999-2001) multicenter surveillance study. Microb. Drug Resist. 9:73-80.
19. Montanari, M.P., M. Mingoia, E. Giovanetti, and P.E. Varaldo. 2001. Differentiation of resistance phenotypes among erythromycin-resistant Pneumococci. J. Clin. Microbiol. 39: 1311-1315.
20. Musher, D.M., M.E. Dowell, V.D. Shortridge, R.K. Flamm, J.H. Jorgensen, P. Le Magueres, and K.L. Krause. 2002. Emergence of macrolide resistance during treatment of pneumococcal pneumonia. N. Engl. J. Med. 346:630-631.
21. National Committee for Clinical Laboratory Standards. 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 6th ed. Approved standard M7-A6. National Committee for Clinical Laboratory Standards. Wayne, PA.
22. Nishijima, T., Y. Saito, A. Aoki, M. Toriya, Y. Toyonaga, and R. Fujii. 1999. Distribution of mefE and ermB genes in macrolide-resistant strains of Streptococcus pneumoniae and their variable susceptibility to various antibiotics. J. Antimicrob. Chemother. 43:637-643.
23. Reinert, R.R., A. Bryskier, and R. Lutticken. 1998. In vitro activities of the new ketolide antibiotics HMR 3004 and HMR 3647 against Streptococcus pneumoniae in Germany. Antimicrob. Agents Chemother. 42:1509-1511.
24. Roberts, M.C., J. Sutcliffe, P. Courvalin, L.B. Jensen, J. Rood, and H. Seppala. 1999. Nomenclature for macrolide and macrolide-lincosamide- streptogramin B resistance determinants. Antimicrob. Agents Chemother. 43:2823-2830.
25. Rodvold, K.A., M.H. Gotfried, L.H. Danziger, and R.J. Servi. 1997. Intrapulmonary steady-state concentrations of clarithromycin and azithromycin in healthy adult volunteers. Antimicrob. Agents Chemother. 41:1399-1402.
26. Schmitz, F.J., M. Perdikouli, A. Beeck, J. Verhoef, and A.C. Fluit. 2001. Molecular surveillance of macrolide, tetracycline and quinolone resistance mechanisms in 1191 clinical European Streptococcus pneumoniae isolates. Int. J. Antimicrob. Agents. 18:433-436.
27. Schmitz, F.J., S. Schwarz, D. Milatovic, J. Verhoef, and A.C. Fluit. 2002. In vitro activities of the ketolides ABT-773 and telithromycin and of three macrolides against genetically characterized isolates of Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae and Moraxella catarrhalis. J. Antimicrob. Chemother. 50:145-148.
28. Seppala, H., M. Skurnik, H. Soini, M.C. Roberts, and P. Huovinen. 1998. A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes. Antimicrob. Agents Chemother. 42:257-262.
29. Shortridge, V.D., G.V. Doern, A.B. Brueggemann, J.M. Beyer, and R.K. Flamm. 1999. Prevalence of macrolide resistance mechanisms in Streptococcus pneumoniae isolates from a multicenter antibiotic resistance surveillance study conducted in the United States in 1994-1995. Clin. Infect. Dis. 29:1186-1188.
30. Song, J.H., H.H. Chang, J.Y. Suh, K.S. Ko, S.I. Jung, W.S. Oh, K.R. Peck, N.Y. Lee, Y. Yang, A. Chongthaleong, N. Aswapokee, C.H. Chiu, M.K. Lalitha, J. Perera, T.T. Yee, G. Kumararasinghe, F. Jamal, A. Kamarulazaman, N. Parasakthi, P.H. Van, T. So, and T.K. Ng. 2004. Macrolide resistance and genotypic characterization of Streptococcus pneumoniae in Asian countries: a study of the Asian Network for Surveillance of Resistant Pathogens (ANSORP). J. Antimicrob. Chemother. 53:457-463.
31. Song, J.H., S.I. Jung, K.S. Ko, N.Y. Kim, J.S. Son, H.H. Chang, H.K. Ki, W.S. Oh, J.Y. Suh, K.R. Peck, N.Y. Lee, Y. Yang, Q. Lu, A. Chongthaleong, C.H. Chiu, M.K. Lalitha, J. Perera, T.T. Yee, G. Kumarasinghe, F. Jamal, A. Kamarulzaman, N. Parasakthi, P.H. Van, C. Carlos, T. So, T.K. Ng, and A. Shibl. 2004. High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study). Antimicrob. Agents Chemother. 48:2101-2107.
32. Sutcliffe, J., T. Grebe, A. Tait-Kamradt, and L. Wondrack. 1996. Detection of erythromycin-resistant determinants by PCR. Antimicrob. Agents Chemother. 40:2562-2566.
33. Syrogiannopoulos, G.A., I.N. Grivea, A. Tait-Kamradt, G.D. Katopodis, N.G. Beratis, J. Sutcliffe, P.C. Appelbaum, and T.A. Davies. 2001. Identification of an erm(A) erythromycin resistance methylase gene in Streptococcus pneumoniae isolated in Greece. Antimicrob. Agents Chemother. 45:342-344.
34. Thornsberry, C., P.T. Ogilvie, H.P. Holley, Jr., and D.F. Sahm. 1999. Survey of susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolates to 26 antimicrobial agents: a prospective U.S. study. Antimicrob. Agents Chemother. 43:2612-2623.
35. Walsh, F., F. Carnegy, J. Willcock, and S. Amyes. 2004. Comparative in vitro activity of telithromycin against macrolide-resistant and -susceptible Streptococcus pneumoniae, Moraxella catarrhalis and Haemophilus influenzae. J. Antimicrob. Chemother. 53:793-796.
36. Waterer, G.W., R.G. Wunderink, and C.B. Jones. 2000. Fatal pneumococcal pneumonia attributed to macrolide resistance and azithromycin monotherapy. Chest 118:1839-1840.
37. Weiss, K., C. Guilbault, L. Cortes, C. Restieri, and D.E. Low. 2002. Genotypic characterization of macrolide-resistant strains of Streptococcus pneumoniae isolated in Quebec, Canada, and in vitro activity of ABT-773 and telithromycin. J. Antimicrob. Chemother. 50:403-406.